コクラン体系的レビューのライフサイクル (2003年−2024年): 図書学的研究
Shiyin Li1, Chong Wu2,3, Zichen Zhang2
1Department of Epidemiology and Biostatistics University of Arizona Tucson AZ USA.
Cochrane evidence synthesis and methods
|August 21, 2025
まとめ
コクランのシステマティック・レビューは 長い開発と更新のタイムラインがあり レビューの種類によって異なります 効率の向上には,自動化と,タイムリーな完了のための標的のサポートが必要になるかもしれません.
科学分野:
- 健康科学
- 医学 研究
- 証拠 に 基づく 医学
背景:
- コクランのシステマティック・レビューは 医療の意思決定に不可欠です
- 関連性には 審査の完了と更新のタイミングが不可欠です
- レビューライフサイクルを理解することは,効率を向上させるための鍵です.
研究 の 目的:
- コクランレビューのライフサイクルを 経験的に評価する.
- プロトコルから公開されたレビューへの移行を分析する.
- 2003年から2024年までの更新パターンと撤回率を調べる.
主な方法:
- コクラン図書館の出版物から抽出したデータ (2003年−2024年).
- DOIベースのユニークなIDで識別されたトピックをレビューします.
- プロトコル発行,レビュー発行,更新,撤回の時間間隔が計算されました.
主要な成果:
- 71. 9% のプロトコルがレビューとなった (中位 25. 7 ヶ月).
- レビューの64. 3%は更新されませんでした. 更新の中間期間は57. 2ヶ月でした.
- 診断と質的レビューでは,プロトコルからレビューまでの時間が長くなりました.
結論:
- コクランのレビューでは,開発と更新の期間が長いことが示されています.
- レビューのライフサイクルは異なるタイプのレビューによって大きく異なります.
- 自動化と標的型支援により 審査の効率とタイミングが向上します
さらに関連する動画
07:50Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
400
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
575
関連する概念動画
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
02:46Chi-square Analysis
38.7K
The chi-square test is a statistical hypothesis test. It is used to check whether there is a significant difference between an expected value and an observed value. In the context of genetics, it enables us to either accept or reject a hypothesis, based on how much the observed values deviate from the expected values.
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
38.7K
01:12Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382
02:11The Cell Cycle Control System
12.6K
The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...
12.6K
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:10Retrovirus Life Cycles
46.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.8K